The market cap of 1.27 B for Myriad Genetics, Inc. in today’s market indicated its current strength, making the company’s shares a lucrative one. The company’s existing price is 20.89 with a change in volume of 1773036. Myriad Genetics, Inc.’s target price was set to 18.67 with an IPO date at 10/06/1995. The Return on Equity currently counts at 9.80%.
Myriad Genetics, Inc. (NASDAQ:MYGN) exhibits a P/E ratio of 18.77 with a forward P/E of 17.56. At present, the PEG is valued at *TBA alongside the P/S ratio of 1.69 and P/B ratio of 1.74. The corporation showed significant change in the EPS section with its current EPS of 1. The EPS growth in the running year displays a value of 58.60%. Myriad Genetics, Inc. NASDAQ has an Earning Per Share for the upcoming year at 58.60%. The EPS growth for the past five (5) years shows a value of 9.20%, whilst the EPS value for the next five (5) years shows a figure of -3.14%. Company has a sales growth for the last five (5) years is valued at 13.40%.
Indicating how profitable Myriad Genetics, Inc. (NASDAQ:MYGN) is relative to its assets, the ROA value is displayed at 6.80%. The ROA for Myriad Genetics, Inc. tells us exactly what earnings were generated from the invested capital. An ROI of 16.50% for Myriad Genetics, Inc. evaluates and compares the efficiency of the various numbers of investments relative to the cost of investments.
The current ratio for Myriad Genetics, Inc. (NASDAQ:MYGN) shows a rate of 4.1 with its quick ratio of 3.5. The long term debt/equity is currently valued at 0.28 with a total debt/equity of 0. The gross margin parades a value of 78.10% with the company running a operating margin of 13.00% and a profit margin of 9.70%.
The 20-day Simple Moving average for Myriad Genetics, Inc. NASDAQ is measured to be 14.32% in conjunction with the 200-Day Simple Moving Average of 6.23%. Company has a 52-Week High of -42.83% and a 52-Week Low of 37.89%. Myriad Genetics, Inc. experienced its Day High at 4.97%, with its Day Low of 19.37%.
The performance week demonstrated a value of 1.91%. The monthly performance exhibited a rate of -2.71% with an annual performance rate of -49.05%. The performance for the year to date shows a rate of 12.06%. The corporation has a weekly volatility of 2.51% resulting a monthly volatility of 2.81%.
Myriad Genetics, Inc. value Change from Open was at 0.05% with a Gap of 11.78%.
*Real time graph of Myriad Genetics, Inc. (NASDAQ: MYGN)
Disclaimer: Drafted figures and information laid out in the above reporting are only a work of the authors. They do not reflect on the certified policy or position of any business stakeholders, financial specialists, or economic analysts. Examples charted in this article above are only cases with information collected from numerous sources. The authority will not be accountable for anyone who makes stock portfolio or financial decisions as per this reporting, which has been constructed only on limited and open source information. Conclusions from the analysis of the editorial shall not portray the position of any analysts or financial professionals.